Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3690

Analgesics Market by Type (Non-opioids, Opioids) and Route of Administration (Oral, Intravenous, Rectal, Transdermal, Topical) - Global Opportunity Analysis and Industry Forecast, 2015 - 2022

LI_161254
Pages: 123
Mar 2016 | 3116 Views
face gplus_n
Author's : Mohd. Adnan Malik
Tables: 45
Charts: 72
twit_n pr_n

Global Analgesics Market is expected to garner $26.4 billion by 2022, registering a CAGR of 7.1% during the forecast period 2015-2022. 

Analgesics, also known as painkillers, are used to treat and reduce pain in the body. Typically, they are used when the pain is severe and becomes unbearable for the patient. Non-opioids, opioids, and compound analgesics (a combination of both opioids and non-opioids) are the major topical analgesic products used globally. The emergence of pain relief, pain management and painkillers are mainly attributed to the increase in acute and chronic diseases, as well as the rising incidence of cancer worldwide.

Opioid drugs are the strongest types of painkillers, which are derived from opium. They are chiefly used for the treatment of moderate to severe pain and are mostly available through prescription. On the other hand, non-opioid drugs are not derived from opium but include acetaminophen. They also include non-steroidal anti-inflammatory drugs (NSAIDs) and are majorly used for the treatment of mild to moderate pain. In addition, non-opioid drugs are sometimes used alongside stronger painkillers. They are mostly available over-the-counter (OTC); however, some NSAIDs, such as Celebrex, Cataflam, and Motrin, are available through prescription only. Different type of pain such as phantom, neuropathic pain and cancer pain would encourage drug discovery. Pain including inflammatory pain, surgical pain, physiologic pain and wound care pain would contribute to the growing demand for analgesics drugs.

The global analgesics market is expected to achieve moderate growth in the near future, majorly because of factors such as increas e in cardiovascular disease, cancer, and arthritis and growing geriatric population. Recurring pain and aches experienced by the ageing population is another factor the helps the market growth. In addition, increasing investments in R&D by the public and private sector, with key emphasis on the classes of compounds for formulating new therapeutics, are further expected to drive the analgesics industry. However, factors such as uncontrolled prescription of opioids, drug abuse, and unregulated government policies are likely to restrain the growth of the global analgesics market.

The report segments the analgesics market on the basis of type, route of administration, and geography. On the basis of type, the market is segmented into non-opioids and opioids. According to the route of administration, it is segmented into oral, intravenous, rectal, transdermal, and topical. Based on the geography, it is categorized into North America, Europe, Asia-Pacific, and LAMEA.

Companies adopt acquisition as their key development strategy in the analgesics industry to increase their market share. A comprehensive competitive analysis and profiles of major market players, such as Bayer AG, Novartis AG, GlaxoSmithKline PLC, Pfizer Inc., Johnson & Johnson, Reckitt Benckiser (RB), Endo Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, and Sanofi, are provided in this report.

Analgesics Market

Analgesics Marketkey Benefits:

  • This report includes a detailed quantitative analysis of the current trends, size and forecasts from 2015 to 2022, which assists in identifying the prevailing market opportunities.
  • Geographically, the analgesics market is analyzed based on key regions such as North America, Europe, Asia-Pacific, and LAMEA.
  • This study evaluates the competitive landscape of the analgesics industry to aid the reader in understanding the competitive environment across the geographic locations.
  • Furthermore, key market players have been profiled in this report and their strategies are analyzed thoroughly. This helps in understanding the competitive outlook on the supply side of the market.
  • Competitive intelligence highlights the business practices followed by leading industry players across various geographic regions.
  • Porters Five Forces analysis extensively covers the perspective of buyers and suppliers, along with the competitive rivalry among companies.
  • SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.

Analgesics Market Key Segments:

By Type

  • Non-opioids
  • Opioids

By Route of Administration

  • Oral
  • Intravenous
  • Rectal
  • Transdermal
  • Topical

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • U.K.
    • Germany
    • Spain
    • Sweden
    • France
    • Russia
    • Denmark
    • Rest of EU
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Indonesia
    • Rest of APAC
  • LAMEA
    • Brazil
    • Venezuela
    • Chile
    • Saudi Arabia
    • UAE
    • Morocco
    • Kenya
    • Nigeria
    • Rest ofLAMEA
 

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond: what to expect by 2027

2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Low bargaining power of supplier
3.3.2 Moderate bargaining power of buyers
3.3.3 Low threat of new entrants
3.3.4 Moderate threat of substitute
3.3.5 Moderate competitive rivalry

3.4 Government regulations
3.5 Research & Analysis

3.5.1 Clinical trials of research studies conducted for analgesics market

3.6 Market dynamics

3.6.1 Drivers
3.6.2 Restraints
3.6.3 Opportunities

Chapter: 4 MARKET BY TYPE, 2015-2022

4.1 Overview

4.1.1 Market size and forecast

4.2 Non-opioids

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Opioids

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

Chapter: 5 MARKET BY ROUTE OF ADMINISTRATION, 2015-2022

5.1 Oral route

5.1.1 Market size and forecast

5.2 Intravenous route

5.2.1 Market size and forecast

5.3 Rectal route

5.3.1 Market size and forecast

5.4 Transdermal route

5.4.1 Market size and forecast

5.5 Topical route

5.5.1 Market size and forecast

Chapter: 6 MARKET BY GEOGRAPHY, 2015-2022

6.1 North America

6.1.1 Key market trends
6.1.2 Key growth factors and opportunities
6.1.3 Market size and forecast
6.1.4 United states

6.1.4.1 Market size and forecast

6.1.5 Canada

6.1.5.1 Market size and forecast

6.1.6 Mexico

6.1.6.1 Market size and forecast

6.2 Europe

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 United Kingdom

6.2.4.1 Market size and forecast

6.2.5 Germany

6.2.5.1 Market size and forecast

6.2.6 Spain

6.2.6.1 Market size and forecast

6.2.7 Sweden

6.2.7.1 Market size and forecast

6.2.8 France

6.2.8.1 Market size and forecast

6.2.9 Russia

6.2.9.1 Market size and forecast

6.2.10 Denmark

6.2.10.1 Market size and forecast

6.2.11 Rest of Europe

6.2.11.1 Market size and forecast

6.3 Asia Pacific

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Japan

6.3.4.1 Market size and forecast

6.3.5 China

6.3.5.1 Market size and forecast

6.3.6 India

6.3.6.1 Market size and forecast

6.3.7 Australia

6.3.7.1 Market size and forecast

6.3.8 Indonesia

6.3.8.1 Market size and forecast

6.3.9 Rest of Asia-Pacific

6.3.9.1 Market size and forecast

6.4 LAMEA

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Brazil

6.4.4.1 Market size and forecast

6.4.5 Venezuela

6.4.5.1 Market size and forecast

6.4.6 Chile

6.4.6.1 Market size and forecast

6.4.7 Saudi Arabia

6.4.7.1 Market size and forecast

6.4.8 United Arab Emirates (UAE)

6.4.8.1 Market size and forecast

6.4.9 Morocco

6.4.9.1 Market size and forecast

6.4.10 Kenya

6.4.10.1 Market size and forecast

6.4.11 Nigeria

6.4.11.1 Market size and forecast

6.4.12 Rest ofLAMEA

6.4.12.1 Market size and forecast

Chapter: 7 COMPANY PROFILES

7.1 Bayer AG

7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Business performance
7.1.5 Key Strategic moves and developments
7.1.6 SWOT analysis

7.2 Novartis AG

7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Business performance
7.2.5 Key strategic moves and development
7.2.6 SWOT analysis

7.3 GlaxoSmithKline PLC

7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Business performance
7.3.5 Key strategies move and development
7.3.6 SWOT Analysis

7.4 Pfizer Inc.

7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Operating business segments
7.4.4 Business performance
7.4.5 Strategic moves and developments
7.4.6 SWOT analysis

7.5 Johnson & Johnson

7.5.1 Company Overview
7.5.2 Company Snapshot
7.5.3 Operating business segments
7.5.4 Business performance
7.5.5 Key strategic moves and developments
7.5.6 SWOT analysis

7.6 Reckitt Benckiser (RB)

7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Business performance
7.6.5 SWOT analysis

7.7 Endo Pharmaceuticals

7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Business performance
7.7.5 Key strategic moves and developments
7.7.6 SWOT analysis

7.8 Bristol-Myers Squibb

7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Business performance
7.8.4 Key strategic moves and developments
7.8.5 SWOT analysis

7.9 Eli Lilly and Company

7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments
7.9.4 Business performance
7.9.5 Key strategic moves and developments
7.9.6 SWOT analysis

7.10 Sanofi

7.10.1 Company Overview
7.10.2 Company Snapshot
7.10.3 Operating business segments
7.10.4 Business performance
7.10.5 Strategic moves and developments
7.10.6 SWOT analysis

List of Figures

FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2022-2027)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2022-2027)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2022-2027)
FIG. 4 TOP INVESTMENT POCKETS OF ANALGESICS MARKET BY ROUTE OF ADMINISTRATION, 2015-2022
FIG. 5 TOP WINNING STRATEGIES
FIG. 6 TOP FACTORS IMPACTING WORLD ANALGESICS MARKET, 2015-2022
FIG. 7 DRUG POISONING DEATHS INVOLVING OPIOID ANALGESICS
FIG. 8 LEADING INTERNAL ANALGESIC TABLET BRANDS, 2015, BASED ON SALES ($MILLION)
FIG. 9 UNITED STATES ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 10 CANADA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 11 MEXICO ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 12 UNITED KINGDOM ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 13 GERMANY KINGDOM ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 14 SPAIN KINGDOM ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 15 SWEDEN ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 16 FRANCE ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 17 RUSSIA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 18 DENMARK ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 19 REST OF EUROPE ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 20 JAPAN ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 21 CHINA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 22 INDIA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 23 AUSTRALIA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 24 INDONESIA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 25 REST OF ASIA-PACIFIC ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 26 BRAZIL ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 27 VENEZUELA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 28 CHILE ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 29 SAUDI ARABIA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 30 UAE ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 31 MOROCCO ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 32 KENYA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 33 NIGERIA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 34
LAMEA ANALGESICS MARKET REVENUE, 2015-2022, ($MILLION)
FIG. 35 REVENUE GENERATED BY BAYER AG (2012-2014)
FIG. 36 BAYER AG, %REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 37 BAYER AG, % REVENUE, BY GEOGRAPHY (2014)
FIG. 38 SWOT ANALYSIS OF BAYER AG
FIG. 39 REVENUE GENERATED BY NOVARTIS AG (2012-2014)
FIG. 40 NOVARTIS AG, % REVENUE BY BUSINESS SEGMENTS (2014)
FIG. 41 NOVARTIS AG. % REVENUE BY GEOGRAPHY (2014)
FIG. 42 SWOT ANALYSIS OF NOVARTIS AG
FIG. 43 REVENUE GENERATED BY GLAXOSMITHKLINE PLC (2012-2014)
FIG. 44 GLAXOSMITHKLINE PLC, % REVENUE BY BUSINESS SEGMENTS (2014)
FIG. 45 GLAXOSMITHKLINE PLC, % REVENUE BY GEOGRAPHY (2014)
FIG. 46 SWOT ANALYSIS OF GLAXOSMITHKLINE PLC
FIG. 47 REVENUE GENERATED BY PFIZER INC. (2012-2014)
FIG. 48 PFIZER INC., %REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 49 PFIZER INC., % REVENUE, BY GEOGRAPHY (2014)
FIG. 50 SWOT ANALYSIS OF PFIZER INC.
FIG. 51 REVENUE GENERATED BY JOHNSON & JOHNSON (2012-2014)
FIG. 52 JOHNSON & JOHNSON, %REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 53 JOHNSON & JOHNSON, % REVENUE, BY GEOGRAPHY (2014)
FIG. 54 SWOT ANALYSIS OF JOHNSON &
JOHSNON
FIG. 55 REVENUE GENERATED BY RECKITT BENCKISER (2012-2014)
FIG. 56 RECKITT BENCKISER, % REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 57 RECKITT BENCKISER, % REVENUE, BY GEOGRAPHY (2014)
FIG. 58 SWOT ANALYSIS OF RECKITT BENCKISER
FIG. 59 REVENUE GENERATED BY ENDO PHARMACEUTICALS (2012-2014)
FIG. 60 ENDO PHARMACEUTICALS, % REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 61 SWOT ANALYSIS OF ENDO PHARMACEUTICALS
FIG. 62 REVENUE GENERATED BY BRISTOL-MYERS SQUIBB (2012-2014)
FIG. 63 BRISTOL-MYERS SQUIBB, % REVENUE, BY GEOGRAPHY (2014)
FIG. 64 SWOT ANALYSIS OF BRISTOL-MYERS SQUIBB
FIG. 65 REVENUE GENERATED BY ELI LILY (2012-2014)
FIG. 66 ELI LILY, %REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 67 ELI LILY, % REVENUE, BY GEOGRAPHY (2014)
FIG. 68 SWOT ANALYSIS OF ELI LILY
FIG. 69 REVENUE GENERATED BY SANOFI (2012-2014)
FIG. 70 SANOFI, %REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 71 SANOFI, %REVENUE, BY GEOGRAPHY (2014)
FIG. 72 SWOT ANALYSIS OF SANOFI

List of Table

TABLE 1 WORLD MARKETBASE CASE SCENARIO MARKET, BY GEOGRAPHY, 2022-2027 ($MILLION)
TABLE 2 WORLD MARKET RAPID GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022-2027 ($MILLION)
TABLE 3 WORLD MARKET DIMINISHING GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022-2027 ($MILLION)
TABLE 4 PORTERS FIVE FORCES ANALYSIS
TABLE 5 CLINICAL TRIALS - ANALGESICS
TABLE 6 GLOBAL INCIDENCES OF DISEASES
TABLE 7 WORLD MARKET, BY TYPE, 2015-2022 ($MILLION)
TABLE 8 WORLD NON-OPIOIDS ANALGESICS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 9 WORLD OPIOID ANALGESICS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 10 WORLD MARKET BY ROUTE OF ADMINISTRATION, 2015-2022 ($MILLION)
TABLE 11 WORLD ANALGESICS ORAL ROUTE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 12 WORLD ANALGESICS INTRAVENOUS ROUTE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 13 WORLD ANALGESICS RECTAL ROUTE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 14 WORLD ANALGESICS TRANSDERMAL ROUTE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 15 WORLD ANALGESICS TOPICAL ROUTE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 16 WORLD ANALGESICS MODE OF APPLICATION BY TYPE, 2015-2022 ($MILLION)
TABLE 17 WORLD ANALGESICS MODE OF APPLICATION BY TYPE, 2015-2022 ($MILLION)
TABLE 18 WORLD MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 19 NORTH AMERICA
ANALGESICSMARKET, BY TYPE, 2015-2022 ($MILLION)
TABLE 20 NORTH AMERICA
ANALGESICSMARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 21 EUROPE
ANALGESICSMARKET, BY TYPES, 2015-2022 ($MILLION)
TABLE 22 EUROPE
ANALGESICSMARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 23 ASIA PACIFIC ANALGESICS MARKET, BY TYPES, 2015-2022 ($MILLION)
TABLE 24 ASIA PACIFIC ANALGESICS MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 25
LAMEAANALGESICSMARKET, BY TYPES, 2015-2022 ($MILLION)
TABLE 26
LAMEAANALGESICSMARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 27 COMPANY SNAPSHOT OF BAYER AG
TABLE 28 BAYER AG OPERATING SEGMENTS
TABLE 29 COMPANY SNAPSHOT OF NOVARTIS AG
TABLE 30 NOVARTIS AG OPERATING
SEGEMENTS
TABLE 31 GLAXOSMITHKLINE PLC SNAPSHOT
TABLE 32 GLAXOSMITHKLINE PLC OPERATING
SEGEMENTS
TABLE 33 COMPANY SNAPSHOT OF PFIZER INC.
TABLE 34 PFIZER INC. OPERATING SEGMENTS
TABLE 35 COMPANY SNAPSHOT OF JOHNSON &
JOHSNON
TABLE 36 JOHNSON &JOHSNON OPERATING SEGMENTS
TABLE 37 COMPANY SNAPSHOT OF RB
TABLE 38 RECKITT BENCKISER OPERATING SEGMENTS
TABLE 39 COMPANY SNAPSHOT OF ENDO PHARMACEUTICALS
TABLE 40 ENDO PHARMACEUTICALS OPERATING SEGMENTS
TABLE 41 COMPANY SNAPSHOT OF BRISTOL-MYERS SQUIBB
TABLE 42 COMPANY SNAPSHOT OF ELI LILY AND COMPANY
TABLE 43 ELI LILY OPERATING SEGMENTS
TABLE 44 COMPANY SNAPSHOT OF SANOFI
TABLE 45 SANOFI OPERATING SEGMENTS

 
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Purchase Full Report of
Analgesics Market- Global Opportunity Analysis and Industry Forecast, 2015 - 2022

  • Online Only
  • $3690
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4099
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $4999
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6004
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $8373
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts